Protein design and engineering are both scientifically exciting and of practical relevance in many areas, includ ing biotechnology and biomedicine. Protein engineering has provided, for example, new enzymes for industrial biocatalysis [1] [2] [3] [4] , highly tailored antibodies for cancer treatment 5, 6 , easily trackable fluorescent proteins for bio logical research 7, 8 and efficient polymerases for forensic DNA detection 9 . Molecular construction using DNA is rapidly catch ing up, as seen in the preparation of DNA aptamers and rationally designed DNA nanostructures [10] [11] [12] [13] [14] [15] [16] [17] [18] . This use of DNA is surprising, as its biological role lies in encoding genetic information and influencing gene expression. Nevertheless, nucleic acids have been retooled into artificial recognition agents and structural scaffolds for applications in materials science, biophysical research and, increasingly, synthetic biology. DNA nanotech nology, in particular, has drastically expanded the rep ertoire of rationally designed nanostructures beyond RNA and DNA aptamers that can bind proteins or other ligands [19] [20] [21] [22] [23] [24] . With protein engineering and DNA nanotechnology growing rapidly, several fundamental questions emerge. What are the relative strengths of polypeptides, DNA and RNA in terms of their structural and functional proper ties, as well as their ease of engineering? Which molecu lar building material is best suited for a given application? Moreover, considering that synthetic biology and nano biotechnology are exciting areas, what are the most promising applications of new bio nanostructures? Answering these questions is important, as protein engineering and DNA nanotechnology are often seen as separate research areas with limited interaction.
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In this Review, we synoptically compare protein, DNA and RNA as building materials for nanostructures with defined architecture and function. By answering the above questions, this Review aims to achieve a uni fied understanding of the strengths and weaknesses of these biopolymers. The Review starts with a side byside evaluation of proteins, and DNA and RNA in terms of their physico chemical properties, the prin ciples for their rational design and engineering and methods for their (bio)chemical synthesis. The ensu ing three sections compare how these differences influ ence the functional performance of protein or DNA nanostructures as biomolecular recognition agents, enzymatic catalysts and structural scaffolds. This includes a discussion of applications in biotechnology, biomedicine, synthetic biology and materials research. A concluding section outlines possible avenues for future research. This Review is written for a broad, interdisciplinary audience interested in biomolecular design with chemical precision.
Properties and structures of biopolymers
Several properties of proteins and DNA affect their engineering, such as chemical diversity, folding, struc tural complexity, compactness and dimensions. The 20 different genetically encoded amino acids from which most naturally occurring proteins are constructed lead to a broad chemical diversity (Box 1; Fig. 1 ). Consequently, there is large scope for non covalent interactions during Comparing proteins and nucleic acids for next-generation biomolecular engineering folding. Hydrogen bonding and non covalent interactions in the polypeptide backbone enable several secondary structures and over 1,300 known protein folds 25 
(Box 1).
An undesirable consequence of structural complexity is misfolding and aggregation 26 . However, in successful outcomes, a charge neutral and conformationally flexible backbone usually yields compact protein architectures of moderate dimensions (<10 nm, average size of 34 kD in bacteria and 49 kD in eukaryotes 27 ), which also reflect the small size of amino acids (Box 1; Fig. 1 ).
DNA and RNA are each built from four standard nucleotides. Hence, the chemical diversity and scope for non covalent interactions in the folding of DNA and RNA are more constrained than those of proteins (Box 1; Fig. 1 ). This is illustrated by the lack of posi tively charged residues and direct ion bridges, even though metal cations can lead to indirect bridges. DNA strands interact primarily through hydrogen bonding between base pairs and hydrophobic base stacking. The reduced scope of interactions leads to fewer fold ing arrangements than are possible for proteins (Box 1; Fig. 1 ). This makes DNA folding easy to predict when Watson-Crick basepaired duplexes (Box 1) are the core element of the architecture. Hoogsteen base pairings expands the range of structures to G quadruplexes or triplexes (Box 1); i motifs are formed by two parallel duplexes rich in cytosine-cytosine pairs. Folded DNA structures are usually less compact than proteins partly because of the electrostatic repulsion of the negatively charged backbone. Furthermore, duplexes with a high persistence length of around 50 nm (reF. 28 ) easily yield up to 100 nm large DNA nanostructures, which also reflect the larger size of nucleotides than amino acids The different characteristics of proteins and DNA influence the creation of new architectures, as differ ent design and engineering approaches are needed to balance the strengths and weaknesses of the biopoly mers. Because of the complex folding of proteins, most approaches rely on the modification of naturally occur ring proteins. Chemical diversity can be controlled by means of rational engineering, which is used to alter a few amino acids or peptide stretches and is often guided by structural insight or computational tools (Box 2). Compared with rational engineering, directed evolu tion samples a wide range of the sequences by creating large gene libraries that encode randomized sequences, expression of the corresponding proteins and screen ing of their properties [29] [30] [31] ; misfolded proteins are dis carded during the screening process (Box 2). Directed evolution methods, such as mRNA display 32, 33 and yeast display cells [34] [35] [36] , are of particular interest. mRNA display achieves a large chemical diversity by creating a library of up to 10 9 members, translating proteins and chemi cally associating them with their encoding mRNA for screening and identification. By comparison, yeast dis play relies on a library with fewer members but obtains proteins with specific biomolecular functions by express ing larger amounts of proteins, post translationally modifying them and displaying them on the cell wall of yeast for easy screening. Computer aided de novo design explores the largest diversity without requiring biolog ical scaffolds as the starting point [37] [38] [39] [40] [41] , yet the design can be inspired by natural templates and use existing component structural units 42 (Box 2; Fig. 1 ). Given the difficult prediction of complex folding, mostly small and compact globular proteins are designed. Designing conformationally dynamic proteins is harder. Yet, higher computing power enables increased protein size and complexity 38 . A powerful strategy is to combine two or more of the above methods to compensate for their isolated drawbacks [42] [43] [44] . Engineering with nucleic acids is different, as the low chemical diversity can translate into less complex folding than in proteins. Novel structures of aptamers 21, 45 are generated via the systematic evolution of ligands by Box 2 | Comparison of engineering and synthesis approaches for polypeptides and nucleic acids Engineering and design Directed evolution: proteins. Directed evolution involves the generation of a large library of randomized mutants of a gene corresponding to a protein with a selectable functional property. The library members are expressed in cells, such as yeast cells or small cell-like vesicles 270, 271 , via ribosome display
272
, mRNA display 32, 33 or with phage particles [34] [35] [36] 273 displaying the selectable proteins
274
. Small libraries of peptide-like oligomers can be obtained via DNA-templated synthesis 140 . Screening is performed to identify variants with the desired functional property 29, 31, 275, 276 and is followed by amplification of the hit mutant genes. The multistep process is iterated.
Directed evolution: DNA and RNA. Systematic evolution of ligands by exponential enrichment (SELEX) technology 19, 20, 24 screens a library of RNA or DNA oligonucleotides with randomized sequences to isolate strands that bind to a target ligand, followed by polymerase chain reaction (PCR) amplification of the strands and additional cycles of screening and amplification.
Rational design: proteins. Rational engineering is best conducted with a high-resolution structure of the protein scaffold that, with computational tools, helps to select those amino acids residues, peptide stretches or even larger units that should be altered via site-directed mutagenesis.
De novo protein design covers a wide range of approaches [37] [38] [39] [40] 277 . Its purest and most challenging form involves ab initio calculations to explore the full protein sequence space for a chosen architecture or function. Suitable structures and sequences are computationally screened by iteratively sampling the side chains (via the rotamers of all amino acids) and checking the structural validity of the backbone 38 to identify protein conformations with a global energy minimum. Some methods utilize as constraints secondary structure and contact predictions. Results can be cross-checked by comparison with approaches that predict structures from known sequences
.
Template-based methods begin with a sequence, predict its secondary structure and attempt to find a template structure and/or fragments from existing scaffolds in the protein databank that will fold similarly to the target sequence 41 .
Folding of the polypeptide into the defined architecture can be an issue because of the complexity of the folding pathways but can be engineered 278 with protein folding in vivo as a correction mechanism
279
. A recent, bioinformaticssupported approach relies on natural evolutionary mechanisms such as domain duplication and fusion as a template for the design of new proteins from fragments of existing proteins 280, 281 .
Rational design: DNA and RNA. In tile assembly [183] [184] [185] [186] , tiles composed of a few hybridized oligonucleotides usually assemble into a regular array. In contrast, classical DNA origami approach 11, 188 uses a set of single-stranded DNA (ssDNA) oligonucleotides to direct the folding of a long ssDNA scaffold strand into a nanostructure with a single 11 or multiple layers of duplexes 188, 189 that are arranged parallel in a square or honeycomb lattice. The design software caDNAno 190 predicts the sequences of staple strands from a user-defined nanoshape of given geometry and dimensions. Curvature can be introduced into DNA origami by inserting or deleting bases to uniformly twist or bend packs of duplexes 193 . Alternatively, DNA origami with different curvatures in neighbouring duplexes are designed on the basis of varying distances between crossovers
194
. DNA origamis can also assemble into larger units through shape complementarity, with duplex protrusions fitting into the designed recession, independent of pairing 196 .
Brick design strategy
201,202 affords short oligonucleotides ('DNA bricks') that assemble into 3D structures without a long scaffold strand. The design units are cubes, which represent an 8 bp interaction between neighbouring strands. Wireframes structures 191, [198] [199] [200] can also be produced, in which straight duplex modules are connected at tuneable angles into a network whereby the sides are not filled with DNA, unlike classical DNA origami.
Synthetic approaches and chemical modifications
Proteins. Synthetic peptides of up to 50 residues can be routinely generated via solid-phase peptide synthesis 282 . one or more synthetic fragments can be coupled via native chemical ligation 242 or linked to biologically generated proteins via expressed protein ligation 241 but also via Staudinger ligation
282
. Biologically generated proteins can be selectively chemically modified 244 or genetically engineered to feature unnatural amino acids 29 .
DNA and RNA. Solid-phase DNA oligonucleotide synthesis 283 can yield up to 200 nt-long strands. longer strands can be chemically linked from smaller units followed by amplification to yield native DNA with the same sequence 284 , or duplexes are assembled from partly overlapping oligonucleotides 285, 286 via PCR. Base and backbone modifications, generally summarized as xeno nucleic acid (XNA), can include backbone analogues of peptide nucleic acid, 1,5-anhydrohexitol nucleic acid, cyclohexene nucleic acid, glycol nucleic acid, locked nucleic acid and threose nucleic acid. These and nucleobase analogues can be generated using chemical synthesis 135, 137, 248, 287 and optionally incorporated via enzyme-mediated polymerization 135, 248 including an expanded genetic code
243
. Chemically modified DNA strands can also be obtained via DNA-templated synthesis to pre-arrange and ligate sequence-defined codons carrying chemically diverse side chains 288 . When a library is generated, this can also include the screening for functional hybrid polymers and identification of this by means of DNA sequencing 288 . exponential enrichment (SELEX) method (Box 2), which is simpler than analogous protein methods, as both func tion and encoding sequence are combined in nucleic acids. Complementary, completely rational de novo design 11, 15, 18 can build a nanosized object of almost any geometry from scratch because folding relies on sim ple base pair rules and a small set of standard structural building units, including DNA duplex units, hairpins and Holliday junctions (Box 2). Rationally designed DNA nanostructures, unlike aptamers, are usually composed of multiple DNA strands and can even reach sizes up to 100 nm. However, single chain DNA origami 46 and co transcriptionally folded single chain RNA nano structures have been prepared 47 . In addition, microscale symmetric DNA origami assemblies 48 and similarly sized arrays with arbitrary patterns are accessible 49 .
Designing and building function Proteins differ considerably from DNA and RNA, and this contrast has consequences for the building of func tional nanostructures, which are relevant in biomed icine, biotechnology, synthetic biology and materials science. The following three sections discuss these dif ferences in light of three representative functions: bio molecular recognition, catalysis and structural support. Other functions, such as motor activity [50] [51] [52] [53] [54] or cellular signal processing and biocomputation 12, 55, 56 , are not covered in this Review, and transmembrane transport by protein versus DNA pores [57] [58] [59] [60] has been compared previously 61, 62 .
Biomolecular recognition
Biomolecular recognition enables the highly specific and tight binding of ligands. Molecular binding agents are thus of relevance in biosensing and biomedicine, as well as in many research applications, including the analy sis of biological cells. We evaluate binding agents by comparing antibodies, antibody derivatives and other protein based recognition scaffolds with DNAbased and RNA based aptamers. The chemical and struc tural properties of proteins and DNA are key because specific and tight recognition requires the side chains of the biopolymers to fit a binding pocket that is struc turally and chemically complementary to the ligand. Furthermore, the engineering strategies used for the diff erent biopolymers strongly influence how easily binding sites are obtained.
Antibodies and antibody derivatives illustrate that proteins excel at specific and tight recognition, and suita ble strategies achieve both properties. Immunglobulin G antibodies are Y shaped structures with two identi cal arms, termed fragment antigen binding (Fab) 63, 64 ( Fig. 2a) ; the bottom stem of the Y shaped structurethe fragment crystallizable (Fc) region -does not interact with antigens but instead interacts with other receptors (Fig. 2a) . b | A designed ankyrin repeat protein (DARPin; blue ribbon) interacting with a signal transduction RAS GDP protein variant G12V (grey), which is involved in cancer development 291 . DARPin repeats have a structural motif of helix-turn-helix-β-hairpin. c | A DNA aptamer inhibitor (red) for lysophospholipase D autotaxin (grey), which is a protein involved in cancer cell motility as well as the adhesion of lymphocytes to immune organs 292 . Scale bars, 1 nm. Part a insert is adapted with permissions from reF.
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, Elsevier. required for the highly specific recognition of ligands. The remainder of the antibody molecule consists of 'constant domains' that vary with immunoglobulin class.
The chemical and structural diversity can be har nessed in biotechnology with the mutational mech anism of antibody producing immune cells using hybridoma technology. In this method, continuously growing hybrid cells -made from antibody producing yet short lived B immune cells and immortal cancer cells -each produce a monoclonal antibody type specific for one recognition motif 65 . This approach uses mouse immune cells, and therefore, the surface of the mice derived antibodies causes immunogenic ity in humans [66] [67] [68] . However, the immune response can be minimized by genetically fusing the mice derived antigen binding loops into a human antibody frame work [66] [67] [68] , thereby expanding their therapeutic applica tions. Alternatively, antigen binding units are sourced from bacterial phage display libraries 69 or yeast librar ies 34, 35 . Both routes generate gene libraries of rand omized sequences outside the cells and then express and screen the proteins. The advantage of using yeast librar ies is that antibodies and other mammalian cell surface and secreted proteins, such as receptors and cytokines, are post translationally modified with carbohydrates to achieve efficient folding and activity 34, 35 . Antibody engineering also yields variants with two different Fabs to recognize two distinct antigens. These bispecific antibodies 5, 63, 70, 71 are used in clinical trials for immune cancer therapy. They recruit cytotoxic T cells to the targeted tumour cells via specific recognition; the Fc part can also help to bind another immune cell, such as a macrophage. Bispecific antibodies are used in other biomedical applications, for example, to colocalize two proteins in cells and test the biological effect 63 . Bispecific antibodies can be produced within a cell line. However, this can result in the uncontrolled combination of the two light and heavy chains present within each cell and inactive isoforms 72 . Rational engineering can overcome the problem by heterodimerizing the heavy chains 70 , even though the pairing with light chains is still uncontrolled. One solution involves the use of a single common light chain 5 ; however, a better alternative is to produce, in two separate cells, two half antibodies, each composed of the matching heavy and light chain. After their purification, the matching antibody halves are then specifically coupled by exploiting the ration ally engineered complementary 'knob inhole' surface structures on the two heavy chains 63 . The cumbersome fabrication of complete antibod ies limits their use in many applications. Engineering approaches can truncate the constant domains of the Fc and Fab regions and stabilize the remaining variable domains of a single Fab by looping the shortened light and heavy chains into a single polypeptide. Owing to their smaller size, these single chain variable fragment antibodies can display higher tissue penetration without compromising affinity 73 . Their antigen binding region can also be optimized with directed evolution using yeast display 34, 35 . Single chain variable fragments find major application in cancer therapy. The fragments are parts of chimeric antigen receptors (CAR) that are engineered onto immunological T cells to recognize tumour cells 6 . The chimeric receptors comprise the extracellular recog nition domain, a genetically fused membrane spanning domain, and an intracellular signalling endodomain 74 . When CARs on T cells bind to cognate surface proteins on tumours, multiple CARs form a lateral cluster in the membrane, which in turn leads to signalling and activa tion and reprogramming of T cells into cytotoxic cells that destroy the cancer cells.
The use of camelid antibodies provides an alternative to the use of large antibodies, as the former naturally lack the light chains 75, 76 . As half of the antibody consists of only a single heavy chain, the constant regions can be removed to leave the remaining single variable domain as a com pact binding agent. These aptly termed nanobodies 77 have high structural stability 76, 78 and are less prone to aggregation 77 . The small units can reach epitopes inacce ssible to larger antibodies 79 and can also be expressed in a form that is fused to green fluorescent protein 80 . Recognition can be engineered into a non antibody scaffold, as shown by designed ankyrin repeat proteins (DARPins) (Fig. 2b) , which are derived from the integral membrane protein ankyrin 81 . A DARPin recognition site is composed of three to five repetitive looped homolo gous units, and because of its modular structure, it mimics the modular recognition principle of ankyrins. The loops are selected by screening a library of 1,000s of different repeat units 82 . DARPins have been used as a crystallization chaperone 83 , as sensors of protein con formation and to induce apoptosis in tumours 84 . The concept of repeat based recognition scaffolds has also been implemented using sequences with leucine rich repeats 85 , a 42residue tetratricopeptide repeat variant 86 , Huntingtin, elongation factor 3, protein phosphatase 2 A and TOR1 (HEAT)like repeats 87 and others 88, 89 . Non antibody recognition scaffolds smaller than DARPins include peptide macrocycles, such as the immu nosuppressant cyclosporine 90 . The macrocycles feature around 8-12 amino acids, including d enantiomers as well as natural l enantiomers, several with non standard side chains. The recognition spectrum of macrocycles has been explored by sampling the available structure space by sequence design and energy landscape calculations 91 . As illustrated above, the chemical variety of polypep tides helps to create strong and specific molecular rec ognition agents. Both biological and in vitro generated libraries can be screened to identify highly functional binders, while rational engineering helps to redesign the overall scaffold. How do RNA and DNA based recognition agents compare to the impressive proper ties of proteins and peptides? RNA and DNA can form remarkably strong and specifically binding aptamers (Fig. 2c) , even though the chemical diversity of endoge nous nucleic acids is lower than that of proteins [21] [22] [23] [24] 45 . A compensatory factor is the relatively short length of RNA or DNA aptamer strands, which makes it easy to explore, via SELEX, a greater physicochemical parameter space than would be possible for proteins 19, 20 . Furthermore, aptamers can address some of the shortcomings of anti bodies. For example, the folded strands are fabricated from commercial chemical synthesis, whereas anti bodies require more complex manufacturing processes that make use of cell based expression systems followed by purification to remove biological contaminants. As a drawback, DNA and RNA make aptamers unsta ble towards nucleases, which can limit their use in therapeutic applications.
Aptamers are used in diagnostics, therapeutics and biosensing and as research tools for cell biology [21] [22] [23] [24] 45 . One clinically approved RNA aptamer is discussed to highlight structural features as well as strategies to address nuclease instability 92 . The aptamer pegaptanib is approved by the US Food and Drug Administration (FDA) and is used against age related macular degeneration. It binds the molecular target vascular endothelial growth factor with an affinity of around 50 pM (reF.
92
). The RNA strand is 27 nt long and folds into a hairpin structure with an internal loop, which is bent into the biologically active 3D conformation. To increase nuclease stability, all the 13 pyrimidines are 2ʹfluorine modified, while 12 of the 14 purines carry the 2ʹO methyl modification. Furthermore, a 40 kDa polyethylene glycol moiety is linked to the 5ʹ terminus to sterically screen nucleases. More aptamers are developed for other diseases 23 . Aptamers can also be integrated into rationally designed nanostructures to achieve multiple recognition capabilities 93, 94 . Compared with antibodies or related structures, aptamers are less widely used in biomedicine. This is not due to the inability of nucleic acids to form aptamers with high selectivity and specificity, or to the lack of suit able engineering methods that can harness the chemical and structural potential; both proteins and nucleic acids rely on screening methods of randomized libraries, as the engineering of binding sites is more difficult with rational design. Rather, the higher use of protein based recognition agents in therapeutics is mostly due to the lower enzymatic stability of DNA or RNA aptamers, as well as filtration by the renal system 21 .
Biocatalysis
Biocatalysis is essential in industrial biotechnology. It helps to synthesize chemicals and pharmaceuti cals 2, [95] [96] [97] , biofuels 98, 99 and foodstuff including proteins and is also useful in biomedicine and biosensing 3 . It furthermore provides an environmentally friendly and cost effective alternative to classical transition metal catalysis 100 . Biocatalysis is enabled by enzymes but can also be mediated by RNAzymes or DNAzymes.
Efficient catalysts accelerate chemical reactions and control which part of the substrate undergoes a specific chemical transformation. The biopolymer residues are key in both cases because fast catalysis requires the active site to weakly bind the substrate but energetically stabilize the reaction transition state. Furthermore, residues achieve chemical selectivity by recognizing the substrate. Industrial applications require biocatalysts that exhibit affinity for a defined range of substrates 98, 101 ; increased rate and yield for the chemical transformations; high stereoselectivity, chemoselectivity and/or regioselectivity 100 ; tolerance to extreme conditions, including high or low temperature, organic solvents and/or inhibitory chemicals 4 . Enzymes are outstanding biocatalysts, as they meet these requirements. With their diverse repertoire of amino acids (various sizes, polarity or charge), active sites are formed to specifically interact with sub strates and transitions states 2, 4, 102 . Several engineering approaches can harness the advantages of proteins and turn them into valuable tools for industrial processes. For example, traditional rational engineering 103 on a nitrilase with a single amino acid replacement increased the enantioselectivity by 11% to 98.5% for the R isomer of a precursor for a cholesterol lowering drug 104 . Directed evolution with libraries exploits a wider chemical and structural repertoire than rational engin eering 29, 30 . One route to diversify the library is gene shuf fling, in which a gene is randomly fragmented and the fragments are then homologously recombined back into a more diverse set of genes via polymerase chain reac tion (PCR) reassembly 105 . Libraries are also diversified by cassette mutagenesis to replace a small subset of a gene with synthetic DNA of a randomized sequence 106, 107 and error prone PCR.
Directed evolution helped to turn ironhaem containing cytochrome P450 into a biocatalyst for the highly enantioselective amination of benzylic C-H bonds 108 , thereby addressing the demand for an efficient and renewable catalyst for this reaction. The cytochrome was also engineered to perform the industrially impor tant anti Markovnikov oxidation of styrenes with high efficiency 109 . The extent of structural rearrangement afforded by directed evolution is illustrated by a retro aldolase. In this case, the reactive lysine originally incorporated into the active site is replaced by a lysine in a new substrate binding pocket 110 ( Fig. 3a) . In a more drastic example, a non catalytic scaffold was converted into an RNA ligase 32 through a complete remodelling of the active site 111 , including enhanced conformational dynamics 111, 112 . This drastic change is likely caused by the in vitro production of the protein library, which does not impose any of the constraints observed in cell based expression. Indeed, the evolution of a metalloenzyme for olefin metathesis via bacterial protein production required the screened enzymes to be located in the bac terial periplasm to avoid metalloenzyme inhibiting glu tathione in the cytoplasm 1 . Similarly, enzymes can also be generated with yeast to display the screened proteins on the cell surface 36, 113 . A greater number of directed changes in the enzyme structure and function can be afforded if evolution and screening are performed with targeted libraries 29, 30 . This process involves combining mutations from different rational design variants with rounds of error prone PCR 114 , sequencing library hits to identify gene segments to be genetically randomized 97 or guiding the creation of randomized libraries with computational design [115] [116] [117] . For example, focused mutagenesis resulted in polysialyl transferase enzymes to produce polysaccharides with a narrow size distribution ideal for glycoengineering appli cations 118 . Computations also enabled the redesign of the active site of an amine transaminase to attain marginal activity for the synthesis of the chiral amine precursor to the antidiabetic drug sitagliptin, which was followed by directed evolution to optimize the enzyme to the man ufacturing settings 100 . In another case, computational approaches were used to develop a statistical model to establish the relationships between catalytic activity and the structures of the interacting small mole cule and protein. This resulted in targeted libraries, as demon strated for a halohydrin dehalogenase to synthesize a precursor for a cholesterol lowering drug 119 . A hydro lytic enzyme composed of a catalytic triad of cysteinehistidine-glutamic acid placed inside a bundle of seven peptide α helices (Fig. 3b) has been designed using computational approaches 120 . The production of Kemp eliminase illustrates the benefit of combining all the previous engineering routes. Kemp eliminase was computationally designed and then subjected to in vitro evolution 115 , which was followed by sequencing to identify gene hot spots of high enzymatic activity and the construction of small focused libraries, resulting in a striking overall 6 × 10 8 fold increase in rate 121 ( Fig. 3c) 124 . Sophisticated cascades can be obtained by exploiting the increase in catalytic rates by several orders of magnitude due to proximity and/or the nanoconfinement of enzymes 125, 126 . Other systems that are appealing for industrial use integrate engineered membrane transporters for whole cell catalysis in order to efficiently transport both substrates and products across the cellular barrier 127 . Similar to proteins, DNAzymes and RNAzymes are obtained via the directed evolution approach. They can catalyse cleavage and ligation reactions of the nucleic acid backbone, the photorepair of DNA and the modification of peptides and small molecules 128, 129 . One exemplary DNAzyme is an RNA ligase of known X ray structure 129 ( Fig. 3d) . The active site and the substrate form a compact folding unit that is stabilized by numerous tertiary inter actions. The regioselectivity of the reaction can also be elucidated by structure guided mutagenesis, which helps to manipulate substrate recognition and the reaction rate. Similarly relevant are RNA polymerase 130 and reverse transcriptase ribozymes 131 . Yet, the absence of DNAzymes or RNAzymes in industrial applications is surprising, as the biotechno logically relevant production of antibodies and enzymes uses ribosomes, which are themselves RNAzymes 132, 133 . However, ribosomes are composed of multiple RNA strands and additional polypeptides. Such a complex multimeric structure does not easily lend itself to drastic reengineering or partial de novo design.
By comparison, catalysts made of only RNA or DNA usually carry out nucleic acid related reactions, as noted above, even though directed evolution can also achieve non RNA and DNA transformations 134 . Furthermore, compared with proteins, most DNAzymes and RNAzymes only modestly accelerate reactions. The narrower catalytic scope and slow speed are con sequences of the smaller chemical parameter space of nucleotides than that of amino acids. Furthermore, the larger size of the nucleotides and the negatively charged DNA or RNA backbone can reduce the structural flexi bility and electrostatic tuneability, which are required for versatile catalysis.
Several of these points are being addressed with non biological xeno nucleic acids, which allow for a greater chemical diversity than would be the case with native nucleic acids [135] [136] [137] (Box 2). An alternative route uses DNA based hybrid catalysis, in which a transition metal com plex is covalently or supramolecularly bound to a duplex. The chiral microenvironment of DNA, in addition to fur ther interactions, enables high enantioselectivities and, often, additional rate accelerations 138, 139 . In the future, this idea may be extended to organocatalysis. In a separate approach, DNA can be used to spatially pre assemble organic reagents to facilitate their proximity induced covalent linkage. In this DNA templated synthesis, short DNA strands -described as codons -are linked to the organic building blocks and sequence specifically hybridize to the DNA template, which then couple the blocks into oligomers, as demonstrated by the synthesis of a macrocycle 140 . By bringing together reagents, DNA fulfils only one function of a catalyst, but it does not stabilize the transition state. DNA templated synthesis has been developed into a tool for material discovery 141 and can also be conducted with DNA based molecular machinery that controls and records the formation of covalent bonds 142 .
Structural support and scaffold
Structural support is the third function of protein, DNA and RNA nanostructures. In biology, protein based cytoskeletal supports define the shape of membranes, organelles and cells but also guide the arrangement of non membrane components, such as chromosomes, at defined positions at length scales of up to a few micro metres. Biological structural supports can contain up to thousands of subunits, in contrast to the monomeric or oligomeric nature of enzymes or antibodies. Another difference is that the function of scaffold proteins relies largely on their nanoscale morphology and dimensions; catalysis is only rarely involved. A similarity is that inter actions with other subunits require a finegrained pro tein surface, which is the same for molecular recognition agents.
In this section, we first describe representative biolog ical protein based structural scaffolds. This is necessary, as their functions are diverse. Then, we discuss newly designed protein assemblies and their applications. To further appreciate the influence of the building material, we finally describe DNA based synthetic scaffolds along with their applications. Natural protein assemblies. Biological protein based scaffolds can be categorized according to their ultras tructural shape, which is related to their biomolecular functions and molecular architecture of the subunits. The available shapes are fibres, sheets and hollow shells.
Microscale rod like and cylinder like fibres physically connect other cellular components and form the intra cellular cytoskeleton (microtubule and intermediate fila ments) and the extracellular matrix. Another example is bacterial pili that form hair like appendages on the cell surface to form contact with other bacteria and can be involved in biofilm formation 143 . Rods and cylinders are also used for intracellular and intercellular transport, such as actin tracks, to move cargo with myosin and other molecular motors, or as rotary hooks for propulsion 143 . Sheet like assemblies are found in bacterial S layers (Fig. 4a) , which function as the sole structural exoskeleton . The SbsB monomer comprises six immunoglobulin-like domains that are looped into a phi-like unit. The N-terminal cell-wall anchoring domain is not included in the struture. The image of the bacterium was rendered following reF.
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. b | M13 bacteriophage filament (grey) composed of a p8 subunit (blue ribbon) 295 . c | Bin1, amphiphysin and Rvs167 (BAR) domain (blue ribbon subunit) and rendering illustrating their binding to a curved membrane (grey) 156 . d | A synthetic protein cage with subunits shown as blue ribbons (top) and as a space-filling model (grey , with subunit shown in blue) 166 . The subunits form a dimer as indicated by different hues of blue in the ribbon representation. One subunit is composed of a timer-forming domain (top in bright blue subunit) and linked via an α-helix to a smaller dimer-forming domain that interacts with the second subunit.
for almost all archaea and in eubacteria as an attachment matrix for exo enzymes or to invade host cells, such as for Bacillus anthracis layers [144] [145] [146] . The SbsB protein lattice from a Gram positive bacterium illustrates this molec ular architecture 147 (Fig. 4a) . The SbsB protein consists of an amino terminal cell wall attachment domain and six consecutive immunoglobulin like domains. The latter domains arrange in a crystallization unit that is stabi lized by interdomain Ca 2+ coordination with histidine and other metal chelating amino acids. This compact unit pre positions the areas of intermolecular contact to facilitate lateral assembly into the protein lattice.
Hollow protein shells, such as viral capsids, define the shape of viral particles, protect the enclosed viral genetic material and facilitate cell surface recognition by hosting membranes through the display of recognition motifs 148 . Typical viral shells have an icosahedral or rod ultras tructure, such as the M13 bacteriophage (Fig. 4b) . The approximately 50 nm wide and a few micrometre long shell is mostly assembled from the major p8 coat protein. p8 interacts via its inner facing, positively charged side with the single stranded circular viral DNA. The two other proteins form the caps of the filament. A related class of protein shells comprises bacterial microcom partments. These organelles enclose different enzymes to initiate catalytic cascades to, for example, fix CO 2 or oxidize carbon sources for energy release 149, 150 . The icosahedral compartment shell usually contains at least two different protein types. The first forms pentamers positioned at the vertices of the icosahedral shell. The second assembles into cyclic hexagons that constitute the facets of the shell 150 . The hexagonal circular units enclose a central pore, which is assumed to facilitate cross boundary exchange of enzymatic substrate and products. The larger enzymes are retained inside the bacterial microcompartment [150] [151] [152] . Another protein cage that can adopt icosahedral symmetry is formed by clathrin. This protein covers cell membranes via a lattice that shapes the membranes into drop like intracellular vesicles to transport enclosed molecular cargo into and out of the cells 153 . The curved lattice is formed by triskelions in which three protru sions are linked with some structural flexibility to the central trimerization domain. Owing to the flexibility, the interaction between the three protrusions can form hexamer as well as pentamer units, yielding lattices with varying numbers of triskelions and symmetries, includ ing icosahedrons. A different and smaller protein shell is ferritin. It is composed of 24 α helical polypeptides and binds iron inside cells, yet it does not adhere to mem branes. By contrast, Bin1, amphiphysin and Rvs167 (BAR) domains, which are found in all eukaryotes, form crescent shaped dimers that bind preferentially to highly curved, negatively charged membranes 154 , thereby shap ing the morphology of the bilayer (Fig. 4c) and facilitating the clathrin independent formation of vesicle pits 155, 156 . Engineered protein assemblies. Which type of protein scaffold can be synthetically produced? Fibres were built via rational design using β strand peptides that assemble into β sheets. Alternatively, amphipathic α helices were designed to interact via coiled coils to bundle into long fibres 157 . If the peptides are straight and short, the fibres extend without branching for up to hundreds of micro metres (reF.
157
). Supplementing additional peptides con taining flexibly linked α helices produced kinked, waved and branched fibres 158 . Furthermore, pre assembled blunt ended coiled coil barrels with central channels were used as building blocks to form peptide nanotubes 159, 160 . 2D nanosheets could be assembled from an α helical amphiphilic peptide. Its threefold screw symmetry led to the hexagonal packing of helices 161 . The design of larger 2D protein lattices had to cope with subunit interfaces that were more corrugated than that of small peptide sub units. To overcome this limitation, longer ranging metal coordination bonds were installed at the protein interface via the suitable electron donors histidine and glutamic acid 162 . The resulting monomeric proteins assembled into micrometer scale planar arrays upon the addition of Zn 2+ , which formed metal coordination bonds with the amino acids to bridge the subunits. Additionally, 2D protein arrays were formed via covalent disulfide bonds between protein subunits that had an inherent C 4 symmetry and assembled into a square lattice 163 . By comparison, a 3D structure was attained by using a single chain α helical polypeptide that folded via coiled coils into the final tetrahedron shaped prod uct 164 . In the alternative and more frequently used multimeric mode, protein cages are assembled from subunit proteins that are genetically coupled from dis tinct oligomeric protein domains in defined geometric orientations 165 . For example, a cube shaped cage with a side length of 22.5 nm was formed by having a trimer at the corners of the cube and a dimer at its edges. The trimer and dimer forming domains were linked with a semi rigid α helical linker 166 ( Fig. 4d) . Alternatively, the linkage could be promoted by non covalent protein interactions 167 . In this case, complementary packing arrangements are first identified by means of compu tational simulations, which are followed by the design of low energy interfaces between the building blocks 168 , often involving only a few amino acid alterations 168, 169 . The approach facilitated the fabrication of a 24subunit, 13 nm diameter octahedron from a trimeric protein building block 167 . Even larger compartments were obtained with heterodimeric and homotrimeric coiled coil peptide bundles that formed hexagonal networks, which closed into spherical cages with diameters of approximately 100 nm (reF.
170
).
Applications of protein assemblies. The multimeric nature of spherical protein assemblies can be exploited in bio medicine to display peptide epitopes for vaccines. The dis play of the antigen parts helps recognition by the immune system and is achieved by genetically linking the haemag glutinin protein to the ferritin subunits. Immunization with the resulting particles resulted in antibody titres tenfold higher than those from a reference vaccine 171 , as multiple copies of the epitope were displayed on the vac cine. A related genetic fusion approach placed poliovirus neutralization epitopes onto nanoparticles formed by the hepatitis B surface antigen protein 172 . The high lateral density of S layer protein lattices finds applications in biotechnology as an immobilization matrix for metabolic enzymes. The resulting catalytic lat tice displayed a longer shelf life than the free enzyme 173 , most likely resulting from conformational stabilization by the lattice 174 . In a similar fashion, the protein shells of bacterial microcompartments have been exploited as high density anchoring sites for new enzymes 175 . Examples of applications of synthetic protein scaf folds in synthetic biology include the fabrication of a virus like protein assembly to encapsulate RNA genomes 43 . The capsid proteins were first computatio nally designed into icosahedral assemblies with positi vely charged inner surfaces to package full length mRNA genomes. Then, the directed evolution of capsid proteins led to a 100fold increase in genome packaging, close to the reference standard of a recombinant adeno associated virus. Existing virion particles that protect DNA were previously engineered as vectors for clinical gene therapy 176 . Natural and engineered protein assemblies can also be exploited to research new materials. The regularity of the protein lattices can be used to spatially organize inorganic materials, such as nanocrystals, with optical, electronic and magnetic properties for information technology. For example, S layers were used to nucleate in situ arrays of 5 nm sized CdS nanocrystals within the pores of the lattice 177 . Different approaches have been explored to directly immobilize arrays of preformed nanoparticles 178, 179 . Protein assemblies have further been employed in materials science to produce arrays of two different types of non biological units, as shown by the engi neered M13 phage into hybrid materials for bioenergy applications 180, 181 . In one study, elongated virus capsids were used to mimic the photosynthetic light driven oxidation of water. Porphyrin photosensitizers and cat alytic reaction centres were chemically linked to the p8 coat proteins of the viruses. Immobilization at tuneable nanoscale spacing on the protein lattice was essential to improve the overall catalytic activity 180 . In a second study, the phage formed nanostructured electrodes for Li ion batteries. To interface with Li, amorphous FePO 4 nanoparticles were grown on the p8 coat protein that had been equipped with a particle seeding glutamic acid tag. Further electrical conduction was introduced by placing at the virus cap peptides that exhibited affinity for single walled carbon nanotubes. Combining the cap sid with nanotubes resulted in a high density network in which electrochemically active nanoparticles were conductively connected through the carbon nanotubes to the metallic electrode base 181 . The above studies illustrate the strengths and limita tions of large protein assemblies. Protein self assembly requires only one to a few types of easily produced pro tein subunits, which give rise to larger order repetitive structures. The regularity is a logical consequence of the small size of proteins and the short persistence length of polypeptides. Nevertheless, repetition can be a limita tion when more complex ultrastructures are required. Biology features less symmetric multicomponent com plexes, for example, in transport 182 and energy conver sion, but their engineering is difficult. Hence, there is currently no protocol to obtain protein assemblies of any geometrical shape or any dimension from 20 to 100 nm.
DNA-based scaffolds. DNA is an alternative building material that can address some of the limitations of proteins. One noted advantage of DNA duplexes is their high persistence length, which makes the production of large non repetitive nanostructures easier. In addi tion, the rational design of DNA structures is greatly facilitated by the simple base pairing rules and the pre dictable folding of DNA strands. Consequently, DNA nanotechnology relies on building de novo architectures with simple structural motifs, such as DNA duplexes, DNA hairpins and Holliday junction based crossovers (Fig. 5a) , as well as motifs with non Watson-Crick base . Closing and opening are induced by modulating the electrostatic repulsion via the salt concentration, thereby switching the arms between a position with blunt-end (BE) stacking and a position without stacking. e | Reconfigurable DNA nanocages (top, red) assemble to complete a ring-like exoskeleton (grey) that templates a circular lipid tube (green) 203 . Scale bar for Holliday junction, 1 nm; other scale bars, 10 nm.
pairs. DNA nanotechnology also exploits the relatively easy prediction of which interconnected units fold from a strand with controllable sequence.
A range of rational design and assembly strategies have been developed for de novo DNA nanostructures (Box 2). Several representative structures are described here to illustrate the scope of DNA nanotechnology. All structures are preceded by the tile based design, in which short DNA strands usually assemble into repetitive arrays [183] [184] [185] [186] . DNA assemblies with highly tuneable shapes and dimensions have been obtained by the origami approach. In this strategy, a set of single stranded DNA (ssDNA) oligonucleotides acts as staples to direct the folding of a long ssDNA scaffold into a nanostructure with non repetitive architecture 11 . The scaffolds are around 7,000 nucleotides long and can lead to nanostructures up to 100 nm. The structures are composed of a layer of parallel aligned duplexes that are held together by mul tiple crossovers (Fig. 5) . Shapes accessible via the design route include rectangles, stars and a smiley face (Fig. 5a) . A box composed of multiple sideways interconnected origami walls was also made 187 ( Fig. 5b) . Its lid could be opened after adding a key oligonucleotide to unlock the duplex based closure mechanism.
The DNA origami approach can be extended to yield structures that are multiple duplex layers thick 188, 189 . The parallel aligned duplexes can be arranged in square or honeycomb lattices. The design of the DNA ori gami structures is greatly facilitated by the caDNAno software 190 . The user inputs the desired geometry and dimensions of the nanostructure, and caDNAno cal culates the sequences of staple strands. However, user experience is required to reposition Holliday junctions to generate robust and stable constructs. Advances in software development have further automated the design process to minimize user adjustments 191, 192 . In addition, the need for staple strands has recently been relieved with the new concept of ssDNA origami, in which a single long nucleic acid strand threads through the nanostructure 46 , similar to co transcriptional folding of a single stranded RNA into the final product 47 . A greater range of morphologies is accessible with curved DNA. In contrast to classical DNA origami with straight helices, twisted or bent building units can be obtained by inserting or deleting bases within duplexes 193, 194 . Bundles of neighbouring DNA duplexes can have the same curvature, and nanostructures resem bling twisted ribbons or triangles have been attained using such DNA duplexes 193 . Alternatively, DNA ori gamis can exhibit different curvatures in neighbouring duplexes that lead to variable distances between cross overs 194 . This curved design approach can be used to form shapes that resemble Genie bottles 194 as well as arrays of clathrin triskelionlike stars that can be assem bled into a planar higher order lattice on supported semifluid bilayer membranes 195 (Fig. 5c ).
Another route to obtain larger non repetitive assemblies relies on 3D shape complementarity 196 . Here, DNA origamis are designed to assemble into even larger units than those obtained in standard DNA origami approaches by virtue of duplex protrusions in one strutural unit and complementary shapes in another unit. The complementary units are stabilized by hydrophobic base stacking between the correspond ing duplexes, rather than direct base pairing. Possible resulting structures include synthetic filaments com posed of Lego like bricks and nanostructures resem bling the human body, which contain three parts: the legs and two body halves with hands (Fig. 5d) . The idea of using bluntend stacking to arrange large units has also been demonstrated with orthogonal DNA ori gami tiles. To achieve programmable assembly, the planar tiles are designed to feature complementary edges composed of alternating protruding blunt ends forming duplex loops and inactive patches 197 . In DNA wireframes, straight duplex modules are con nected at tuneable angles into a network, allowing the formation of regular geometries, such as tetrahedrons 198 or octahedrons 199 , or more exotic architectures, such as nanoscale rabbits, bottles or spirals 191, 200 . The creation of regular or irregular shapes can be guided depending on the use of short DNA oligonucleotides alone 198 or with a DNA scaffold that threads through the structure 191, 199, 200 . In a brick like design 201, 202 , short oligonucleotides ('DNA bricks') assemble into 3D structures in which the design units are cubes that include an 8 bp interaction between neighbouring strands. This design helped to create a complete alphabet at the nanoscale.
Applications of DNA-based scaffolds. One application of rationally designed DNA lies in synthetic biology, in which it is used to mimic the function of proteinaceous cytoskeletons that shape lipid bilayers [203] [204] [205] . DNA scaf folds offer more extensive control over morphology and size of the membrane supports than protein structural supports. Membrane anchoring is achieved by attaching tags, such as cholesterol 206, 207 , as observed in the case of flat nanobarges 195, [208] [209] [210] , and origami bricks that can also deform vesicle bilayers 211 . A related study has shown, however, that hydrophobic tags attached to cuboid DNA cages can interact with themselves in the absence of a membrane. The cages form defined, quantized oli gomers, such as dimers, trimers or tetramers, that are stabilized by hydrophobic interactions 212 . DNA nanostructures can be used to modulate the shape of the lipid bilayers. For example, simple DNA rings with a size of up to 200 nm were built to control the diameter of spherical bilayer vesicles formed within the ring 213, 214 . The DNA templates helped to homogenize the size of conventional vesicles. Unconstrained vesicles are heterogeneous in size, and this can be an issue for biophysical research as well as for the use of cargo loaded vesicles in bioimaging and biomedicine. In a different route, a spherical nanoscaffold was coated with a bilayer membrane to generate a virus like particle 215 . With further development, this approach could prolong the half life of vesicle enclosed drugs.
Membrane morphologies including tubes, rings, spirals and organelle like vesicle arrays were made with a modular DNA design 203 . The corresponding DNA scaffolds were assembled from multiple interconnected nanocages, each composed of two open DNA rings or squares and four connecting pillars (Fig. 5e) . The presence of lipid anchors inside the cages enables lipos omes to assemble in this confined space. By shortening the pillars, the vesicles were brought together and fused into elongated membrane tubes. Asymmetric short ening formed wedge like cages that produced nano scale doughnuts and similarly shaped membrane rings (Fig. 5e) . In a related approach, BAR like DNA origami rods with different degrees of curvature were shown to induce membrane bending and deformation of vesicles on the micrometre scale 205 . When added in excess, the curved DNA rods wrapped around closely, stabilizing the lipid nanotubes 205 . Membrane vesicles with controlled dimension and geometry could help to understand the relation between the morphology of the membranes, its lipid composition and its dynamics. A related topic of interest is how the curvature of the membrane alters the activity of membrane proteins within the photosynthetic or oxidative respiration systems 216 . DNA origami also helped to pioneer a new fluores cence microscopic imaging method that realizes high spatial resolution 217 . Classical high resolution methods can suffer from the short lifetime of the fluorophores and insufficient localization. By attaching an ssDNA tag to the molecule of interest, the multiple transient binding of complementary oligonucleotides with fluo rescent labels could enhance the overall signal strength and improve resolution. The method was pioneered with a DNA origami plate featuring multiple DNA exten sions for hybridization 217 . It can also help to structurally characterize 3D DNA polyhedra in solution 218 . DNA nanostructures have also been designed to probe changes in intracellular pH. The sensor featured an i motif section, which switches between an open and closed state depending on the pH. The fluorescent emis sion of a fluorophore pair placed on the i quadruplex provides information on pH changes between 5.8 and 7. The DNA nanostructure helped map the pH of early endosomes and the trans Golgi network in real time 219, 220 . DNA nanostructures can also be used in the field of materials science as templates to guide the assembly of individual polymers in designed patterns. This approach has facilitated the study of the properties of single polymer strands, which are useful to generate molecular scale electronic devices and optical wires 221 . DNA nanostructures can also act as scaffolds to spatially control the assembly of nanoparticles 15 . Nanoparticles with plasmonic properties are of particular interest because of their possible applications in optical 222 , electronic 223 and photonic devices 223, 224 . As the collec tive properties are affected by the particle distance and arrangement 15, 224 , DNA strands have been used as spac ers to control the lattice periodicity and symmetry of nanoparticle assemblies 225, 226 . DNA nanotechnology can help to attain more com plex arrangements of nanoparticles than accessible with DNA strands. For example, a 2D DNA array was used to assemble a chess board pattern of alternating 5 nm and 10 nm gold nanoparticles 227 . Strand displacement allowed switching of particles and changes in the geom etry of the structures 228 . For more complex 3D pattern ing, nanoparticles were organized in a regular pattern around DNA nanotubes 229 and in a helical arrangement around nanorods 230 . The precise position of the particles is reflected in the circular dichroism spectrum. DNA ori gami nanoantennas were also built to enhance the flu orescence intensity of dyes. A dye molecule was placed in a plasmonic hot spot of zeptolitre volume between two 100 nm gold nanoparticles and showed a 117fold increase in fluorescence 231 . DNA nanostrutures have also been used as a mould to create nanoparticles with predesigned 3D shapes and surface modifications 232 . Stiff DNA structures were designed, and the scaffold was used to enclose a small gold cluster, which was then grown into a nanoparticle that assumed the shape of the container. Cuboid and tri angular nanoparticles, as well as nanoparticles of more complex geometries, were generated with this approach. The moulding strategy can be extended to create poly mer clusters inside of the DNA cage 233 . The remaining DNA strands on the exterior lead to programmable poly mer assembly. DNA cages can also be used to print DNA sequences onto gold particles 234 . Furthermore, DNA origami has guided the produc tion of 3D plasmonic crystals by enclosing gold nano particles inside DNA origami tetrahedra, which were then linked to a diamond superlattice 235 . The placement strategy has been adapted to couple molecular emitters to optically resonating photonic crystal cavities. This approach was based on the predictable binding of DNA origami onto nanopatterned surfaces with cavities 236, 237 . DNA scaffolds modified with different numbers of dyes were positioned onto the photonic crystal cavities. The tuning of the light intensity by each resonating cavity resulted in a nanoscale reproduction of The Starry Night by Van Gogh 238 .
Conclusions and outlook
This Review has raised and addressed a simple question: how do the different chemical properties of proteins and polynucleic acids influence the engineering of nanos tructures and their functions? To answer this question, the two building materials were compared in terms of biochemical properties and ease of engineering. These two aspects have been compared by looking at two main features of the biopolymers: chemical and structural diversity, and predictable easy folding. Although both features are desirable, they are not always exhibited by a single biopolymer type. Proteins are chemically and structurally diverse, but this inherently makes rational design challenging. By comparison, DNA is less diverse but stands out because of its programmable folding into predictable nanostructures. This is a general compari son, as highly functional structures can also be obtained by means of advanced directed evolution methods.
Biopolymers have been evaluated for three exemplary functions. In the case of biomolecular recognition, both proteins and nucleic acids achieve strong and specific binding. This is easy to understand for proteins owing to their great chemical parameter space. For nucleic acids, the limited chemical diversity is compensated by rich directed evolution libraries. By comparison, biocataly sis in industry is dominated by enzymes owing to their larger chemical and structural diversity and fast catalytic speed; directed evolution is still the central approach, even though computational design is gaining trac tion. Finally, the building of structural supports can be achieved with proteins but is more easily attained with DNA nanostructures, which often outperform proteins in several applications. For both protein and DNA based structural supports, rational design with computational tools is the principal approach in use thus far.
What are areas of growth and possible future trends for research? Within protein engineering, the ever increasing computational power will facilitate the de novo design of proteins by better predicting poly peptide folding 38 . In addition, combining rational design with directed evolution will gain popularity given the considerable benefits. The advantages of this combined approach have been highlighted by the fabri cation of artificial protoviruses and efficient enzymes whose essential protein scaffolds were computationally designed but then functionally optimized via directed evolution 43, 91 . A long term aim is to design enzymes for any given chemical transformation.
Another area of interest is protein hybrids that inte grate two functions, such as structural support and catalysis. Inspirational templates are bacterial microcom partments, where protein scaffolds spatially concentrate enzymes to accelerate chemical transformations owing to the reduced diffusion distances [149] [150] [151] [152] . Synthetic ana logues are intracellular filaments made from assembled bacterial microcompartment shell proteins engineered to capture enzymes 239 . Furthermore, the biocatalyti cally important stoichiometry of enzyme components within a pathway could be controlled by using scaffold bearing interaction domains that specifically recruit the enzymes 240 . In both cases, enzyme confinement led to an overall increased catalytic activity compared with iso lated enzymes. Future research on metabolite membrane transporters could help organize more enzyme path ways to improve metabolic flux for industrially relevant chemical synthesis.
The functionality of proteins can also be enhanced with non natural amino acids that are introduced via peptide synthesis 241, 242 , by a reprogrammed genetic code 243 or by post synthesis chemical modifications 244 .
Such chemical precision can turn proteins into tools to probe, image and control protein function or provide val uable protein therapeutics 243, 244 . The benefit of chemically coupling small molecules is illustrated by therapeutically potent antibody-drug conjugates 245 . The conjugates spe cifically recognize cancer cells and simultaneously deliver their cytotoxic drug payloads. A considerable research interest is to improve the conjugate quality by avoiding the semi random coupling of the drugs with lysine resi dues at the sensitive antigen binding sites 246 . Therefore, current research aims to develop and apply site selective reactions that link drugs at defined positions, including the antibody disulfide bonds 247 . The expansion of nanostructures' functions and ease of their productions are growing trends in aptamer and DNA nanotechnology. To exploit the potential of the nucleic acid structures, their limited chemical variety is addressed by using chemically modified nucleotides 248 that can improve, for example, the molecular recognition of aptamers 136 . Furthermore, the scalable and inexpensive production of DNA origami is of relevance to open up applications in biomedicine and therapy
12
. For classical DNA origami, staple strands are chemically synthesized on a small scale, which is a limitation, whereas scaffolds strands are sourced from cells. Using a new approach, staples along with scaffolds can be made within bacterial hosts, avoiding synthetic reactions. The encoded staple sequences were enzymatically prepared, as they were cut by two lateral Zn 2+ dependent DNAzymes 249 . In another route, staple strands were made by a new design and folding programme in order to exploit the self folding of single DNA or RNA strands into complex yet unknotted structures 46 . In DNA wireframes the need for staples was reduced by enzymatically backfilling singlestranded sections with a polymerase 250 . These approaches will help to deliver applications of nucleic acid nanostructures in, for example, therapy or the intracellular reorganization of biological components 12, 15 . Developing biomedical and therapeutic appli cations can further exploit strategies to make DNA nanostructures compatible with the immune system of higher organisms 251 and utilize a growing fundamental understanding of the cellular uptake and processing of DNA nanostructures 252 as well as their designed func tion inside cells 56 . As a further advantage, nucleic acid structures can help to advance biomedical applications with programmable intracellular biocomputation for the triggered delivery of therapeutic cargo to target cells 55 or for biosensing 61, 253 . Bringing DNA nanos tructures closer to biomedicine can also harness the experience gained from stabilizing aptamers in bodily fluids. Other areas of growth include the development of computational tools to guide and enhance the fold ing accuracy of DNA origami 254 or to increase the sta bility of DNA strands towards nucleases for biological or therapeutic applications.
Hybrid nanostructures composed of proteins and nucleic acids are also of considerable interest 255 , as the combined strength of the two components can compen sate for their isolated weaknesses. This is well illustrated by the ribosome, which is composed of RNA and poly peptides strands (Fig. 6a) . Several simpler hybrid systems of catalytic function have been engineered. For exam ple, DNA scaffolds have been used to spatially arrange multiple enzymes or cofactors in nanostructures to enhance catalytic turnover 256 , similar to biological cat alytic cascades in confined environments 125, 126 . Similar benefits were obtained for a DNA nanocage that encloses enzymes 257, 258 ( Fig. 6b) and a DNA nanorod that links two enzymes and an artificial swinging arm to channel substrates between the enzymes 259 . Furthermore, the activity of an enzyme was controlled by tethering it into a closable DNA vault. The unit could be opened by a DNA key to thereby allow the enzyme to regain steric access to the chemical substrates and restore catalytic activity 260 However, structurally less ordered assemblies can also result in catalytic enhancement, as shown by linking enzymes to intracellular flexible RNA assemblies 261 . Hybrid nanostructures are also excellent tools in cell biology research. For example, DNA scaffolds can be used to expose activating protein ligands to cells in well defined arrangements, with full control over pro tein number, stoichiometry and nanoscale distance 262 .
DNA nanostructures also act as templates to study the movement of molecular motors 53 . The combined use of proteins and DNA scaffolds can further create new defined geometries 263 , as illustrated by a DNA tetrahe dron whose vertices are stabilized with duplexbinding protein RecA 264 . Finally, hybrid strutures enable new function by puncturing the lipid bilayer with pores to facilitate transport of large molecular cargo between the membrane barrier (Fig. 6c) . In these hybrids, a ring shaped DNA scaffold arranges multiple tethered membrane spanning peptide subunits into a contiguous pore of unusually large nanoscale diameter 265, 266 .
In conclusion, this Review has described how the different properties of proteins and nucleic acids define their rational design, engineering, function and suita bility for specific applications. Although the building materials are different, there is considerable scope for working together and synergistically combining their strengths.
Published online 5 July 2018
